This announcement is a separate document:
广济药业：上海信公科技集团股份有限公司关于湖北广济药业股份有限公司2021年限制性股票激励计划回购注销部分限制性股票相关事项之独立财务顾问报告
Hubei Guangji Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Technology Group Co., Ltd. on matters relating to the repurchase and cancellation of some restricted stocks under the 2021 Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.